Merck cuts 51 jobs as it closes Inspire site

On August 31, Merck will officially close the Raleigh, NC headquarters of Inspire Pharmaceuticals, an eye drug specialist that the company bought in April for $430 million. At the time of the purchase, Inspire had 60 employees; Merck said 51 positions would be eliminated when the facility closes later this summer. Report

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.